# 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer

> **NCT03809078** · PHASE2 · COMPLETED · sponsor: **Andrei Iagaru** · enrollment: 14 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 68Ga RM2
- **DRUG:** 68Ga-PSMA-11
- **DEVICE:** Investigational PET scanner coils and software

## Key facts

- **NCT ID:** NCT03809078
- **Lead sponsor:** Andrei Iagaru
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-14
- **Primary completion:** 2022-03-08
- **Final completion:** 2022-03-08
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03809078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03809078, "68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03809078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*